Objective-To investigate pretrial risk factors and long term mortality in participants and nonparticipants of a multifactorial primary prevention trial. Design-A prospective study among 3313 initially healthy businessmen. During the 1960s (1964 onwards), 3490 healthy male business executives born between 1919 and 1934 participated in voluntary health checks at the Institute of Occupational Health in Helsinki. From that period cardiovascular disease (CVD) risk factors were available in 3313 men. In the beginning of the 1970s these men were invited to join a multifactorial primary prevention trial of CVD. Six groups were formed: (I) healthy participants in a high risk intervention group (n = 612), and (II) their randomised control group (n = 610); (III) a non-participant low risk group (n = 593); (IV) an excluded group with signs of CVD (n = 563); (V) a refused group (n = 867); and (VI) dead (n = 68). Groups I and II participated in the five year prevention trial which started in 1974. Other groups were followed up through registers, with no personal contact. (1974)(1975)(1976)(1977)(1978)(1979)(1980)(1981)(1982)(1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992)) mortality (per 1000) was 79.3, 106 6, 155-2, 179-9, and 259 3 in the low risk, control, intervention, refused, and excluded groups, respectively (P < 0.001). In the whole population of 3313 men, the 28-year total (n = 577) and coronary deaths (n = 199) were significantly predicted by smoking, blood pressure, and cholesterol; cancer deaths (n = 163) by smoking only; and violent deaths (n = 83) by none of the risk factors. One-hour postload glucose was significantly associated with total mortality in the intervention group only. When the intervention and control groups were included in the same model, the effect of group on total mortality tended to be dependent on the 1 h blood glucose value (P = 0*06 for the group by 1 h glucose interaction term). Conclusion-The traditional risk factors (smoking, blood pressure, and cholesterol) are significantly associated with 28-year mortality in this high social class population with previous health education. Conversely, a "clustering" of low risk factors predicted low total, coronary, and cancer mortality. The findings on 1 h blood glucose suggest that factors related to glucose tolerance explain in part the excess mortality in the intervention group compared with the control group. (Br Heart_j 1995;74:449-454) 
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Objective-To investigate pretrial risk factors and long term mortality in participants and nonparticipants of a multifactorial primary prevention trial. Design-A prospective study among 3313 initially healthy businessmen. During the 1960s (1964 onwards), 3490 healthy male business executives born between 1919 and 1934 participated in voluntary health checks at the Institute of Occupational Health in Helsinki. From that period cardiovascular disease (CVD) risk factors were available in 3313 men. In the beginning of the 1970s these men were invited to join a multifactorial primary prevention trial of CVD. Six groups were formed: (I) healthy participants in a high risk intervention group (n = 612), and (II) their randomised control group (n = 610); (III) a non-participant low risk group (n = 593); (IV) an excluded group with signs of CVD (n = 563); (V) a refused group (n = 867); and (VI) dead (n = 68). Groups I and II participated in the five year prevention trial which started in 1974. Other groups were followed up through registers, with no personal contact. Measurements-Cardiovascular risk factors during the 1960s. Mortality follow up using national registers up to 31 December, 1992. Main results-Baseline risk factors were lowest in the low risk group, highest in the excluded group, intermediate and comparable in other groups. Eighteenyear (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) ) mortality (per 1000) was 79.3, 106 6, 155-2, 179-9, and 259 3 in the low risk, control, intervention, refused, and excluded groups, respectively (P < 0.001). In the whole population of 3313 men, the 28-year total (n = 577) and coronary deaths (n = 199) were significantly predicted by smoking, blood pressure, and cholesterol; cancer deaths (n = 163) by smoking only; and violent deaths (n = 83) by none of the risk factors. One-hour postload glucose was significantly associated with total mortality in the intervention group only. When the intervention and control groups were included in the same model, the effect of group on total mortality tended to be dependent on the 1 h blood glucose value (P = 0*06 for the group by 1 h glucose interaction term). Conclusion-The traditional risk factors (smoking, blood pressure, and cholesterol) are significantly associated with 28-year mortality in this high social class population with previous health education. Conversely, a "clustering" of low risk factors predicted low total, coronary, and cancer mortality. The findings on 1 h blood glucose suggest that factors related to glucose tolerance explain in part the excess mortality in the intervention group compared with the control group. fig 2) . However, the present analysis of the background population of 3313 men gives an important new perspective on this outcome. The initial setting of the study and the data linkage with the national death register offered a unique chance of obtaining information on pretrial risk factors and survival follow up from men who refused to participate in or were excluded from the actual prevention trial. The present results show that the low risk group-as defined by the cardiovascular risk factor status in the 1960s and 1974-continues to have the best prognosis after 18 years. This concerns not only coronary, but cancer and total mortality as well. Furthermore, those who refused the intervention trial fare even worse than the intervention group. On the other hand, smoking, serum cholesterol, and blood pressure also significantly predicted total deaths in this population of high social class. Unexpectedly, baseline smoking (smoker/non-smoker) did not significantly predict coronary mortality (RR 1-22, 95% 089 to 1-67), but the effect is probably diluted by smoking cessation over the follow up years. As a whole, the Helsinki Businessmen Study results cannot be interpreted as refuting the current idea of cardiovascular risk factors.
The "cholesterol debate" has particularly involved the issue of associations between low cholesterol and non-cardiovascular mortality.'1-13 These concerns have been opposed'4-6 -most recently by the results of the 4S (Scandinavian Simvastatin Survival Study'7) -and they were not supported by the present study which showed increasing total mortality with increasing serum cholesterol. Multivariate analyses suggested that a 1 mmol/ litre rise in total cholesterol implies an 11% increase in mortality. The result is in accordance with earlier experience in Finland from show an association between low cholesterol and cancer. In our study cancer deaths were not significantly associated with initial cholesterol in different analyses and the group with low risk for cardiovascular disease also had the lowest cancer mortality. The rate of non-illness deaths (including accidents, suicide, and homicide) was significantly higher in the intervention than in the control group.3 On the other hand, a high rate of such deaths was observed in the low risk group. The rates of non-fatal violent events were also similar in these three groups.25 The difference between intervention and control groups may thus be due to a chance, that is, an exceptionally low incidence in the control group. It has been suggested that low serum cholesterol or cholesterol lowering is associated with violent death"-"3 26 but the mechanisms are speculative, and, for example, a recent study from North Karelia did not find this association.27 In the Helsinki Businessmen Study population, violent events were not associated with initial serum cholesterol, and in the intervention group fatal and nonfatal violent events were not predicted by intrial hypolipidaemic drug use.25 On the other hand, these events were independently associated with use of alcohol, which is an important possible confounding variable.
It has been suggested that the associations observed in some studies between low cholesterol and total or non-cardiovascular deaths are due to confounding factors.28 29 In the recent analysis by Law et al'6 low cholesterol was associated with excess deaths in community based studies, but not in employed cohorts. In accordance with this, no J curve was observed between cholesterol and total mortality of the whole cohort in the present study of businessmen.
Two findings in the present analyses do not support obvious doubts4 that the randomisation of the intervention and control groups could have been unsuccessful. First, as presented in table 1, the risk factor levels between these two groups were similar before and after randomisation. Second, unlike in the other groups, age was not a significant predictor of deaths in the intervention group (table 3), implying that there were modifying factors (intervention methods) on mortality. Taking into account that both blood pressure and cholesterol predicted mortality in the background population, the significant decrease of these risk factors during the intervention2 should have improved prognosis in the intervention group. As this was not the case, a chance finding-such as the low mortality caused by violence in the control group -or more likely something in the intervention methods needs to be considered as a possible explanation for the unexpected result.' The present findings may offer an additional potential clue. As shown in table 3, 1 h glucose significantly predicted mortality in the intervention group but not in the control group, despite similar baseline glucose concentrations and significant weight reduction in the intervention group during the intervention period.2 The fact that the effect of group on total and coronary heart disease mortality was no longer significant when the group by 1 h glucose interaction term was added to the model suggests that factors related to glucose tolerance explain a part of the excess mortality in the intervention group compared with the control group. Aspects of the intervention methods-possibly mental stress induced by intense health education in the dominant executives, or blood pressure medications8 30 -may have made individuals with impaired glucose tolerance especially vulnerable.
In conclusion, this study shows that the traditional cardiovascular risk factors3" are also important predictors of mortality among men of the highest social class. Cholesterol was specifically associated with cardiac deaths and its impact on total mortality seemed to be determined by the proportion of coronary deaths to total deaths. In this population, where confounding factors (initial diseases, different life styles, or social class) were minimised, no evidence was found for an association between low cholesterol and non-vascular or non-illness deaths. The value of studying homogeneous populations to enhance internal validity has also recently been discussed in the context of body weight and mortality.'2 However, the important questions remain: what is the optimal treatment to lower the risk factors in primary prevention and what are the target levels for intervention? Apparently the intervention methods were not optimal in the Helsinki Businessmen Study. Consequently, the unconventional results of this trial should-rather than calling for pessimism-stimulate more research to find better intervention methods for the primary prevention of cardiovascular diseases.
